Reported Effects Weight reduction (no diabetes): In REDEFINE 1, CagriSema 2.4 mg + 2.4 mg produced roughly 22.7% mean weight loss at 68 weeks (trial-product estimand), though this fell short of the ~25% Novo Nordisk had guided toward [1]
The MS spectra, MS/MS spectra, isotopic ratios, mass accuracy, and chromatographic t R were matched with compounds in the Human Metabolome Database (HMDB, the LIPID MAPS Structure Database ( mzCloud ( and ChemSpider ( P values were calculated using the Students t test using JMP software
Medical directors need to review protocols, especially if a patient doesn't respond after 4-6 weeks, side effects appear, or new regulations come up
Many community protocols cite 200 to 500 mcg per day for injection, extrapolated from rodent data
As a blend of 4 peptides, the dosing takes into account the concentration of each component
PubChem.